Quarterly Earnings

Facing a shareholder revolt after a damning indictment, Supermicro launches a major probe into a $2.5B shadow trade scheme. Is it too little, too late?

With its Q1 earnings call on May 7, STARZ faces investor scrutiny on subscriber growth, content strategy, and its path to profitability post-spinoff.

With its lead cancer drug advancing and a strong balance sheet, Nurix will detail its vision for protein degradation at a key investor conference.

A new report reveals a major education gap in obesity care. Informed patients are now demanding options beyond blockbuster drugs like Wegovy and Zepbound.

As Molson Coors preps its Q1 2026 earnings call, all eyes are on its strategy to combat declining volumes and rising costs in a pivotal "reset year."

Outset Medical appoints Derick Elliott as commercial EVP, a strategic move to accelerate its Tablo dialysis system and capitalize on the hospital insourcing trend.

As Ryan Specialty preps its Q1 2026 results, investors watch to see if the firm can rebound from a tough quarter and navigate a complex insurance market.

Axe Compute names Kyle Okamoto President, a strategic hire signaling a major push to solve the AI 'distribution problem' and challenge hyperscaler dominance.

Newsweek names Bloom Energy a top trustworthy company. We explore how 25 years of reliability, investor confidence, and market demand are shaping its future.

Amidst rising costs and market volatility, Centene appoints two new Group Presidents. Is this strategic overhaul the key to future growth and profitability?

The bank's Q1 2026 earnings show improved interest margins and steady dividends, painting a picture of resilience in a complex Hawaiian economy.

The lender hits its highest rank on Fortune's Best Companies list, but does a celebrated internal culture translate to success in a challenging economy?

As Corebridge Financial prepares to report Q1 results on May 4, investors are watching to see if its 2025 momentum can weather new industry challenges.

Amidst major losses and a declining core business, China's Quhuo bets its future on a high-stakes pivot to housekeeping and vehicle exports, fueled by AI.

PNC declared a steady $1.70 dividend, underscoring its robust financial health and commitment to delivering consistent shareholder returns.

Cheer Holding enacts a 1-for-3 reverse stock split to avoid delisting. But with a history of similar moves, what does this mean for investors?

Following a strong earnings report, Rezolve AI's CEO Dan Wagner has acquired 9 million shares, signaling deep insider confidence in its vision.

IFF targets the booming pet wellness market with PureStrong™, a probiotic built from canine science. Is this the future of dog digestive health?

A Pennsylvania marketing firm and its clients land on prestigious growth lists, proving a specialized strategy in trade industries is a powerful formula.

With international sales now making up nearly 60% of its revenue, the heavy industry giant is diversifying into humanoid robots and emerging markets.